Lacy P E
Washington University School of Medicine, St. Louis, USA.
Hosp Pract (1995). 1995 Jun 15;30(6):41-5. doi: 10.1080/21548331.1995.11443212.
About 20 years after investigators began work on the isolation of animal islets, we are now poised to use such cells to control blood sugar levels in humans. Studies in various laboratories have led to development of transplantation techniques that obviate the need for chronic immunosuppression; equally important, the techniques also appear to avoid the problem of graft rejection.
在研究人员开始致力于分离动物胰岛约20年后,我们现在已准备好使用此类细胞来控制人类的血糖水平。各个实验室的研究已促成了移植技术的发展,这些技术无需长期免疫抑制;同样重要的是,这些技术似乎也避免了移植物排斥问题。